Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record history remains unchanged, with the same version list and study-status change entries.
    Difference
    0.1%
    Check dated 2026-11-08T23:42:53.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T23:44:11.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website changes and says that, during a transition, some NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.8%
    Check dated 2026-10-25T23:13:29.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T23:32:39.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T23:33:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    On the Record History page, the label for finding contact information was changed from 'Find contact information' to 'Find Contact Information', and the revision tag was updated from v3.6.6 to v3.7.0 to reflect a newer version.
    Difference
    0.2%
    Check dated 2026-09-20T22:53:08.000Z thumbnail image

Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.